Supplementary Table S1 from A Phase IB Trial of the PI3K Inhibitor Alpelisib and Weekly Cisplatin in Patients with Solid Tumor Malignancies
Autor: | Pamela N. Munster, Mark M. Moasser, Jennifer Grabowsky, Scott Thomas, Delaire Fattah, Jose Garcia, Romain Pacaud, Susan Calabrese, Edwin A. Alvarez, Emily K. Bergsland, Mallika S. Dhawan, Rahul R. Aggarwal, Erica S. Tsang |
---|---|
Rok vydání: | 2023 |
DOI: | 10.1158/2767-9764.22545363.v1 |
Popis: | A) Rationale for study drug dose interruption or reduction; B) Rationale for cisplatin dose interruption or reduction; C) Cisplatin dose intensity, stratified by dose level |
Databáze: | OpenAIRE |
Externí odkaz: |
načítá se...